ANALYSIS OF THE EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY BY PREGNANT WOMEN ACCORDING TO THE DAILY BLOOD PRESSURE MONITORING

Dorogova Inna Vladimirovna, Candidate of medical sciences, associate professor, sub-department of therapeutics, general medical practice, endocrinology and gastroenterology, Penza state institute of advanced medical studies, i.dorogova@mail.ru
Bartosh Leonid Fedorovich, Doctor of medicine, professor, head of sub-department of therapeutics, general medical practice, endocrinology and gastroenterology, Penza state institute of advanced medical studies, rodino091@rambler.ru
Kuznetsova Tatyana Nikolaevna, Candidate of medical sciences, senior laboratory assistant of the “Nephrology” course, Penza state institute of advanced medical studies, kuznetcovatn@pnz.ru, panina.es@mail.ru
Tuzov Sergey Leonidovich, Candidate of medical sciences, associate professor, head of sub-department of pediatrics, Penza state institute of advanced medical studies, sergejtuzov@yandex.ru

616.12-008; 331.1:618.3

The very narrow spectrum of medicines is used in the capacity of antihypertensive therapies during pregnancy. It doesn`t meet up-to-date requirements of cardiology and uses in connection with their proved safety for a fetus and further development of the child. Such medicines according to the literature are Methyldopa and Clonidine. The purpose of our research was the estimation of results of treatment of arterial hypertension at pregnant women by Methyldopa in a daily doze of 750 mg and Clonidine in a daily doze of 0,15 mg on data of 24-hours monitoring of blood pressure.

arterial hypertension, pregnancy, 24-hours monitoring of blood pressure, methyldopa, clonidine, results of treatment.